ATE356217T1 - Rekombinante mikroorganismen - Google Patents

Rekombinante mikroorganismen

Info

Publication number
ATE356217T1
ATE356217T1 AT00958787T AT00958787T ATE356217T1 AT E356217 T1 ATE356217 T1 AT E356217T1 AT 00958787 T AT00958787 T AT 00958787T AT 00958787 T AT00958787 T AT 00958787T AT E356217 T1 ATE356217 T1 AT E356217T1
Authority
AT
Austria
Prior art keywords
seq
recombinant microorganisms
promoter
protein
mucosal
Prior art date
Application number
AT00958787T
Other languages
English (en)
Inventor
Richard William Titball
Helen Lisa Bullifent
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244633&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE356217(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9921275.5A external-priority patent/GB9921275D0/en
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE356217T1 publication Critical patent/ATE356217T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00958787T 1999-09-10 2000-09-06 Rekombinante mikroorganismen ATE356217T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921275.5A GB9921275D0 (en) 1999-09-10 1999-09-10 Recombinant microorganisms
GBGB0017000.1A GB0017000D0 (en) 1999-09-10 2000-07-12 Recombinant microorganisms

Publications (1)

Publication Number Publication Date
ATE356217T1 true ATE356217T1 (de) 2007-03-15

Family

ID=26244633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00958787T ATE356217T1 (de) 1999-09-10 2000-09-06 Rekombinante mikroorganismen

Country Status (8)

Country Link
EP (1) EP1210445B1 (de)
JP (1) JP2003509046A (de)
AT (1) ATE356217T1 (de)
AU (1) AU777298B2 (de)
CA (1) CA2382067A1 (de)
DE (1) DE60033823T2 (de)
GB (1) GB2369618B (de)
WO (1) WO2001019974A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026203A2 (en) 2003-09-18 2005-03-24 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Dna promoters and anthrax vaccines
GB0501540D0 (en) * 2005-01-25 2005-03-02 Univ Leeds Controlled production and delivery of biologically active agents by gut bacteria
BRPI0615593A2 (pt) * 2005-08-30 2011-05-24 Commw Scient And Ind Reseaech Organisation liberação bacteriana de polipeptìdeos biologicamente ativos
EP1984022A2 (de) * 2006-01-17 2008-10-29 CREATOGEN Laboratories GmbH Influenzaimpfstoff
CN112546210A (zh) * 2020-12-15 2021-03-26 南京农业大学 一种沙门菌灭活疫苗的制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695983A (en) * 1990-12-18 1997-12-09 The General Hospital Corporation Salmonella vaccines
US5733760A (en) * 1994-08-05 1998-03-31 Virus Research Institute Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof
ATE231184T1 (de) * 1995-03-13 2003-02-15 Secr Defence Impfstoffe gegen die pest
ES2286905T3 (es) * 1998-12-02 2007-12-01 University Of Maryland, Baltimore Sistema de estabilizacion de plasmidos para el suministro de antigenos.

Also Published As

Publication number Publication date
AU7020600A (en) 2001-04-17
GB2369618A (en) 2002-06-05
DE60033823T2 (de) 2007-12-06
DE60033823D1 (de) 2007-04-19
WO2001019974A2 (en) 2001-03-22
JP2003509046A (ja) 2003-03-11
EP1210445A2 (de) 2002-06-05
WO2001019974A3 (en) 2001-11-15
GB0203213D0 (en) 2002-03-27
GB2369618B (en) 2004-06-02
EP1210445B1 (de) 2007-03-07
CA2382067A1 (en) 2001-03-22
AU777298B2 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
ATE352626T1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
DK0618976T3 (da) Syntetisk DNA-sekvens med forbedret insekticid virkning i majs
WO2001047952A3 (en) Insecticidal proteins from bacillus thuringiensis
DK1165791T3 (da) Humant cytokin som zalpha-receptor-ligand og anvendelse deraf
NZ595496A (en) Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
FI882456A0 (fi) Human proapolipoprotein a-i expression.
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
TR199501182A2 (tr) Pestisid özellikte yeni proteinler ve suslar.
CA2185712A1 (en) Enhanced virus-mediated dna transfer
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
EP1988099A3 (de) Insektizide Proteine von Bacillus thuringiensis
ATE130869T1 (de) Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen.
DE60043428D1 (de) POLYPEPTIDE MIT VERZWEIGUNGSENZYM-AKTIVITäT UND FüR DIESE KODIERENDE NUKLEINSäUREN
AU2002230691A1 (en) Putrescine-n-methyltransferase promoter
DE60033823D1 (de) Rekombinante mikroorganismen
BR0008187A (pt) Controle biológico de nematódeos
ATE310823T1 (de) Expressionssystem zur produktion von proteinen in pilzen
WO2000006713A3 (en) Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
WO2002051238A3 (en) Recombinant dna vectors for expression of somatotropins
DE60026049D1 (de) POLYPEPTIDE MIT GLUCANOTRANSFERASE AKTIVITÄT UND DAFüR KODIERENDE NUKLEINSÄUREN
ATE288491T1 (de) Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren
EP1757618A3 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsaüre
DE60033562D1 (de) Künstliche promotoren zür protein expression in pflanzen
WO2002000708A3 (en) Mutants of prostase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties